Latest Articles

Publication Date
TET3 is a common epigenetic immunomodulator of pathogenic macrophages.

Through a combination of single-cell/single-nucleus RNA-sequencing (sc/snRNA-seq) data analysis, immunohistochemistry, and primary macrophage studies, we have identified pathogenic macrophages characterized by TET3 overexpression (Toe-Macs) in three major human diseases associated …

Published: Aug. 12, 2025, midnight
Mismatch Repair Status Predicts Endometrial Cancer Outcomes - Medscape

Mismatch Repair Status Predicts Endometrial Cancer Outcomes Medscape

Published: Aug. 11, 2025, noon
Mismatch Repair Status Linked to Endometrial Cancer Outcomes, Real-World Study Reveals - Medscape

Mismatch Repair Status Linked to Endometrial Cancer Outcomes, Real-World Study Reveals Medscape

Published: Aug. 11, 2025, noon
Anti‑inflammatory and anti‑migratory properties of wild‑grape‑derived ε‑viniferin in human endometrial cells:  A potential therapy for endometriosis.

Endometriosis is a chronic gynecological disorder characterized by the ectopic growth and proliferation of endometrial tissue outside the uterine cavity, leading to inflammation. Although low‑dose contraceptive pills are widely used …

Published: Aug. 8, 2025, midnight
Breaking Down Barriers: Improving Access to Quality Endometriosis Care.

Endometriosis affects an estimated 200 million women globally, yet significant barriers hinder access to timely and appropriate care. These barriers encompass various aspects, including societal normalization of menstrual pain, leading …

Published: Aug. 7, 2025, midnight
Cervical endometriosis mimicking cervical adenocarcinoma: A case report.

Cervical endometriosis is a rare benign condition characterized by ectopic endometrial glands and stroma within the cervix. Its clinical and imaging features resemble those of cervical adenocarcinoma, making preoperative diagnosis …

Published: Aug. 7, 2025, midnight
Breakthrough: New Cancer Drug Ampligen Delivers Promising Results in Pancreatic, Ovarian, and Breast Cancer Trials - Stock Titan

Breakthrough: New Cancer Drug Ampligen Delivers Promising Results in Pancreatic, Ovarian, and Breast Cancer Trials Stock Titan

Published: Aug. 6, 2025, 1 p.m.
Harnessing the CD16-PI3Kγ axis in peritoneal CD14hi macrophages: A transformative approach to endometriosis management.

Endometriosis (EMS) is a prevalent estrogen-dependent gynecological disorder characterized by ectopic growth of endometrial tissue. Central to its pathophysiology, peritoneal CD14hi macrophages exhibit a pro-EMS phenotype and drive disease progression. …

Published: Aug. 6, 2025, midnight
Identification of Candidate Genes for Endometriosis in a Three-Generation Family with Multiple Affected Members Using Whole-Exome Sequencing.

Background: Endometriosis is a chronic inflammatory condition affecting 10-15% of women of reproductive age. Genome-wide association studies (GWASs) have accounted for only a fraction of its high heritability, indicating the …

Published: Aug. 6, 2025, midnight
Endometriosis survivors share their pain of misdiagnosis, financial strain - NTV Uganda

Endometriosis survivors share their pain of misdiagnosis, financial strain NTV Uganda

Published: Aug. 5, 2025, 7:06 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!